Related Experiment Video

Updated: Apr 15, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

Improved Long-Term Prognosis of Dilated Cardiomyopathy With Implementation of Evidenced-Based Medication - Report

Ryoichi Ushigome1, Yasuhiko Sakata, Kotaro Nochioka

  • 1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine.

Circulation Journal : Official Journal of the Japanese Circulation Society
|April 3, 2015
PubMed

Insights

Dilated cardiomyopathy (DCM) patient prognosis in Japan improved significantly due to evidence-based medication. This study observed reduced mortality rates and increased use of key heart failure drugs.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • Dilated cardiomyopathy (DCM) is a significant cardiovascular condition.
  • Understanding recent trends in DCM clinical characteristics, management, and prognosis in Japan is crucial.

Purpose of the Study:

  • To examine the evolving clinical characteristics, management strategies, and long-term prognosis of dilated cardiomyopathy (DCM) patients in Japan.
  • To compare patient cohorts from two distinct study periods to identify changes over time.

Main Methods:

  • Comparative analysis of two cohorts of DCM patients from the Chronic Heart Failure Analysis and Registry in the Tohoku District (CHART)-1 (2000-2005) and CHART-2 (2006-present) studies.
  • Evaluation of baseline characteristics, comorbidities, medication use, and 3-year mortality rates between the two cohorts.

Main Results:

  • Prevalence of hypertension, dyslipidemia, and diabetes mellitus increased significantly from CHART-1 to CHART-2.
  • Use of beta-blockers and aldosterone antagonists increased, while loop diuretics and digitalis decreased.
  • Three-year mortality rate significantly improved from 14% to 9%, with a notable decrease in cardiovascular death, particularly in patients with specific clinical profiles.

Conclusions:

  • Long-term prognosis for dilated cardiomyopathy patients in Japan has improved.
  • The implementation of evidence-based medication has contributed to better patient outcomes in DCM.
Abstract

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

9.0K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
579
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
330
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
909